1.
Li C, Yang Z, Xie J, Long Y. A Novel Multi-analyte Serum Panel Combining CA-125, HE4, microRNA-200a, and Interleukin-6 for the Preclinical Detection of High-Grade Serous Ovarian Carcinoma in Women with Pathogenic *BRCA1/2* Variants: Serum CA-125, HE4, microRNA-200a, and Interleukin- Serous Ovarian Carcinoma. J Med Biochem [Internet]. 2026 Jun. 1 [cited 2026 Jul. 12];. Available from: https://asistent.ceon.rs/index.php/jomb/article/view/65630